SHREYA granted India import license on 9/5 likely due to Oralyn getting thumbs up at the 8/14 NDAC endocrinology meeting....news should be soon IMO....and by first week of Oct...AE reports the great progress on the breast cancer vaccine....that will finally bust the warrant wall and bring multiples here...finally....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.